MGYR:NASDAQMagyar Bancorp, Inc. Analysis
Data as of 2026-06-01 - not real-time
$17.30
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
MGYR trades at $17.30, just below its 20‑day SMA of 17.45 and the 200‑day SMA of 17.36, indicating a modest short‑term weakness. The RSI sits at 46.5, well under the overbought threshold, while the MACD histogram is negative, signaling bearish momentum. Volume is rising but remains thin (≈2.6 k shares), and the price is hugging the identified support at $16.78 with resistance near $17.69.
On the valuation side, the stock’s trailing P/E of 9.7 is far below the industry average of 16.6, and the price‑to‑book of 0.86 places it under its book value of $20.08 per share. Operating margins of 43% and a profit margin of 30% underline a strong earnings profile, while the 7.2% revenue growth adds a modest growth tilt. The dividend yield of 2.31% with an 18% payout ratio suggests the dividend is comfortably sustainable.
Risk metrics show a low beta of 0.29, indicating limited market‑wide volatility, yet the 30‑day volatility of 18% and low average daily volume point to liquidity risk. The company’s regional focus in New Jersey limits geographic exposure, and regulatory risk remains typical for U.S. community banks. Overall, the combination of defensive valuation and solid fundamentals makes MGYR a potential upside play for patient investors.
On the valuation side, the stock’s trailing P/E of 9.7 is far below the industry average of 16.6, and the price‑to‑book of 0.86 places it under its book value of $20.08 per share. Operating margins of 43% and a profit margin of 30% underline a strong earnings profile, while the 7.2% revenue growth adds a modest growth tilt. The dividend yield of 2.31% with an 18% payout ratio suggests the dividend is comfortably sustainable.
Risk metrics show a low beta of 0.29, indicating limited market‑wide volatility, yet the 30‑day volatility of 18% and low average daily volume point to liquidity risk. The company’s regional focus in New Jersey limits geographic exposure, and regulatory risk remains typical for U.S. community banks. Overall, the combination of defensive valuation and solid fundamentals makes MGYR a potential upside play for patient investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD histogram
- Price below 20‑day SMA
- Proximity to near‑term support at $16.78
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued P/E vs industry
- Strong operating margin of 43%
- Sustainable dividend yield 2.31%
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Price below book value
- Low beta indicating defensive profile
- Consistent revenue growth of 7%
Key Metrics & Analysis
Financial Health
Revenue Growth7.20%
Profit Margin30.03%
P/E Ratio9.7
ROE9.36%
ROA1.07%
P/B Ratio0.9
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI46.5
Support$16.78
Resistance$17.69
MA 20$17.45
MA 50$17.45
MA 200$17.36
MACDBearish
VolumeIncreasing
Fear & Greed Index94.07
Valuation
GradeUndervalued
TypeBlend
Dividend Yield2.31%
Risk Assessment
Beta0.29
Volatility18.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.